Gabelli & Co Investment Advisers’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-257,763	Closed	-$44.5M	–	213
2015 Q1	$44.5M	Buy	+257,763	New	+$37.8M	7.46%	1

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Gabelli & Co Investment Advisers's SLXP Position: Q2 2015 in Review

Gabelli & Co Investment Advisers sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 257,763 shares — an estimated $44.5M sold.

Gabelli & Co Investment Advisers first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $44.5M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Gabelli & Co Investment Advisers reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 257,763 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $44.5M.
Gabelli & Co Investment Advisers first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Gabelli & Co Investment Advisers's SALIX PHARMACEUTICALS LTD DEL position peaked at $44.5M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2015, filed 5 Aug 2015.